Lord, Abbett & Co’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-197,279	Closed	-$3.88M	–	528
2025 Q1	$3.88M	Sell	197,279 -188,932	-49%	-$3.72M	0.01%	479
2024 Q4	$8.69M	Buy	386,211 +65,156	+20%	+$1.47M	0.03%	401
2024 Q3	$8.2M	Buy	+321,055	New	+$8.2M	0.03%	419